Medical/Pharmaceuticals
Brii Biosciences Announces the Completion of Enrollment in the Phase 3 National Institutes of Health (NIH) ACTIV-2 Trial, Evaluating the BRII-196 and BRII-198 Monoclonal Neutralizing Antibody Combination for the Treatment of COVID-19
846 outpatients at high risk of clinical progression have been enrolled in the ACTIV-2 phase 2/3 clinical study, from sites inthe United States, Brazil, South Africa, Mexico and Argentina. The participants are being evaluated for the combined endpoint of hospitalizations and death relative ...
2021-08-05 22:46
5905
ArisGlobal Lauded by Frost & Sullivan for Enabling Life Sciences Companies to Accelerate R&D with Its LifeSphere® Platform
LifeSphere® ably supports clients by expediting decision-making, maintaining compliance, and streamlining collaborations among cross-functional teams SANTA CLARA, Calif., Aug. 5, 2021 /PRNewswire/ -- Based on its recent analysis of the North American clinical development and pharmacovigilance so...
2021-08-05 21:55
3028
Insilico Medicine and Usynova Announce Strategic Partnership on Accelerating R&D of Small Molecule Innovative Drugs with AI
SHANGHAI, Aug. 5, 2021 /PRNewswire/ -- Insilico Medicine, an industry leader in
end-to-end artificial intelligence for target discovery, small molecule
chemistry, and clinical development, and Usynova announced to reach strategic
cooperation in advancing the development of novel therapies.
2021-08-05 18:23
4123
CUHK Discovers Children with Autism Have Delayed Gut Microbiome Maturity and Identifies Faecal Bacterial Markers for Autism
HONG KONG, Aug. 5, 2021 /PRNewswire/ -- The Faculty of Medicine of The Chinese University of Hong Kong (CU Medicine) reports a ground breaking discovery that children with autism spectrum disorder (autism) showed delayed gut microbiome maturity compared with typically developing children. They ha...
2021-08-05 16:40
5316
KYOWA Pharmaceutical Industry Co. Ltd. Partners with Bora Pharmaceuticals to Manufacture Generic Product for Filing in Japan
TAIPEI, Aug. 5, 2021 /PRNewswire/ -- KYOWA Pharmaceutical Industry Co. Ltd., a premier Japanese pharmaceutical company, has contracted with Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals for the manufacturing of generic product for filing inJapan. KYOWA will be...
2021-08-05 14:50
2734
Inmagene and Kissei Enter into an Exclusive License Agreement for Fostamatinib in China
SHANGHAI and SAN DIEGO and NAGANO, Japan, Aug. 5, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene") and Kissei Pharmaceutical Co., Ltd. ("Kissei") announced today that they have entered into an exclusive license agreement for the development and commercialization of fostamatinib in ma...
2021-08-05 14:00
3985
Everest Medicines Announces Approval of Clinical Trial Application by China NMPA for Phase 3 Trial of Xerava(TM) for Community-Acquired Bacterial Pneumonia
SHANGHAI, Aug. 5, 2021 /PRNewswire/ -- Everest Medicines
2021-08-05 13:12
5203
Chinese Multinational Technology Company, HUAWEI, Aligns With Singapore-Based Healthtech Start-up PLANO to Tackle the Global Problem of Myopia
SINGAPORE, Aug. 5, 2021 /PRNewswire/ -- Shenzhen, Guangdong, China, and Singapore – Huawei Technologies Co. Ltd. (hereinafter, Huawei) and Plano Pte. Ltd. (hereinafter, Plano) today announced their partnership to address the global problem of myopia. Through this partnership, Huawei and Plano wil...
2021-08-05 10:00
3025
Over 3,000 units of HFNC delivered to Poland and Peru, Micomme Medical helps the world fight against COVID-19 pandemic
CHANGSHA, China, Aug. 5, 2021 /PRNewswire/ -- Recently, Micomme has associated with Polish and Peruvian partners to accomplish the government centralized purchase of 1,600 and 1,500 units of HFNC respectively. Both purchases are strategic material reserves of the local governments. The global pa...
2021-08-05 09:55
3155
A New Approach to Dealing With Shortsightedness (Myopia) & Dry Eye in Children
PETALING JAYA, Malaysia , Aug. 5, 2021 /PRNewswire/ -- VISTA Eye Specialist (VISTA) is one of the first among eyecare professionals inMalaysia to adopt an all-in-one diagnostic tool - the MYAH by Topcon, that offers the essential tools for shortsightedness (myopia) management and also as an evol...
2021-08-05 08:00
5855
Wealth Dynamix Wins 'XCelent Functionality Award' in New Wealth Management CRM Report
LONDON, Aug. 5, 2021 /PRNewswire/ -- Wealth Dynamix
2021-08-05 06:58
3993
Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine
GAITHERSBURG, Md., Aug. 4, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced that it has reached an agreement with the European Commission (EC) for the purchase of up to 200 million doses...
2021-08-04 21:10
10472
New Global Study Reveals Post-Pandemic Consumer Behaviours, Expectations and Concerns
Enduring appeal of in-store shopping, and continued fears about data privacy among surprising findings in "Future of Commerce |The Why Behind the Buy" LONDON, Aug. 4, 2021 /PRNewswire/ -- As the marketing industry worldwide continues its efforts to both map and navigate the post-pandemic commerce...
2021-08-04 19:00
1835
MitraClip implant at Apollo Hospitals saves 41-year-old farmer who waited 91 days for heart transplant
"1 out of 5 patients may get off the heart transplant list if they have access to this therapy" - says Dr. Sai Satish CHENNAI, India, Aug. 4, 2021 /PRNewswire/ -- Apollo Hospitals, Asia's foremost and most trusted healthcare group, today announced a successful MitraClip implant on a 41-year-old ...
2021-08-04 18:50
3330
Insilico Medicine Announces the Preclinical Candidate for Kidney Fibrosis Discovered Using End-to-End Artificial Intelligence Engine
HONG KONG, Aug. 4, 2021 /PRNewswire/ -- Insilico Medicine, a global company specializing in the applications of the next-generation machine learning technologies for drug discovery and development, announced today that its AI-powered drug discovery platform had delivered the preclinical candidate...
2021-08-04 18:11
3256
Columbia Clinic signed a cooperation agreement with Boehringer Ingelheim
SHANGHAI, Aug. 4, 2021 /PRNewswire/ -- On August 3rd, 2021, Columbia China, signed a cooperation agreement with Consanas Rehabilitation, brand of Boehringer Ingelheim. The agreement will allow both parties to complement each other's medical resources and to carry out in-depth collaboration on tal...
2021-08-04 16:19
2049
Clarivate Acquires Bioinfogate, Reinforcing Position as Premier Provider of End-to-End Research Intelligence Solutions for Life Sciences
LONDON, Aug. 4, 2021 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today announced that it has acquired Bioinfogate, a leading provider of analytics solutions in the life sciences and producer of the ...
2021-08-04 16:00
36354
OPEN Health acquires Spirit
LONDON, Aug. 4, 2021 /PRNewswire/ -- OPEN Health has today announced the acquisition of North West UK-based medical communications agency Spirit. Integrating the Spirit business with the OPEN Health Group further strengthens our ability to offer our global Medical Affairs audiences a broad range ...
2021-08-04 16:00
1894
NaviFUS begins FUS combined with radiotherapy clinical trial for the treatment of terminal primary brain tumors
TAIPEI, Aug. 4, 2021 /PRNewswire/ -- NaviFUS' focused ultrasound (FUS) therapy system (NaviFUS®) was recently approved for use in a new clinical trial by the Taiwan Food and Drug Administration (TFDA). It will be initiated shortly at Linkou Chang Gung Memorial Hospital. The trial will investigate...
2021-08-04 11:50
2601
TIENS Group will Become a Global Participant in the Future Massive Health Industry
TIANJIN, China, Aug. 4, 2021 /PRNewswire/ -- As announced proudly by TIENS Group's Chairman Li Jinyuan in theHealth Industry Development Forum of the Belt and Road in the Post-pandemic Era held in Tianjin, China, TIENS Group is poised to become one of main global participants in the future massiv...
2021-08-04 00:40
3996
Week's Top Stories
Most Reposted
Visa and Trip.com Group Ink Strategic Collaboration, Enabling Consumers to Chase Their Passions Through Travel
[Picked up by 309 media titles]
2026-05-19 18:10
Two-day Global Prosperity Summit 2026 officially opens
[Picked up by 308 media titles]
2026-05-19 23:59
Two‑day Global Prosperity Summit 2026 concludes successfully
[Picked up by 303 media titles]
2026-05-21 22:13
Hyundai Motor Group to Pioneer Hong Kong's Hydrogen Economy, Accelerating Asia-Pacific Expansion
[Picked up by 290 media titles]
2026-05-18 15:30
Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
[Picked up by 280 media titles]
2026-05-20 09:15Most Read
PT Telkom Indonesia (Persero) Tbk 2025 Annual Report on Form 20-F
2026-05-16 00:26
7914
Eyes that photosynthesise: NUS scientists plant a cure for dry eye disease
2026-05-16 11:14
5825
Lepro Introduces STV1, a TV Backlight That Combines Screen Sync, AI Lighting, and Easier Setup
2026-05-16 00:00
5661
NYSE Content Update: Armada Raises $230 Million, Boosts Valuation to $2 Billion
2026-05-19 21:02
5231
